These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9869190)

  • 1. Prevention and treatment of hepatic venocclusive disease after high-dose cytoreductive therapy.
    Richardson P; Bearman SI
    Leuk Lymphoma; 1998 Oct; 31(3-4):267-77. PubMed ID: 9869190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic veno-occlusive disease following hematopoietic stem cell transplantation.
    Richardson P; Guinan E
    Acta Haematol; 2001; 106(1-2):57-68. PubMed ID: 11549778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Veno-occlusive disease in hematopoietic stem cell transplantation recipients.
    Sosa EC
    Clin J Oncol Nurs; 2012 Oct; 16(5):507-13. PubMed ID: 23022934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide.
    Shah MS; Jeevangi NK; Joshi A; Khattry N
    J Cancer Res Ther; 2009; 5(4):312-4. PubMed ID: 20160371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
    Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
    Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation.
    Toh HC; McAfee SL; Sackstein R; Cox BF; Colby C; Spitzer TR
    Bone Marrow Transplant; 1999 Oct; 24(8):891-5. PubMed ID: 10516702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation].
    Gozdzik J; Krasowska-KwiecieĊ„ A; Wedrychowicz A
    Przegl Lek; 2008; 65(4):203-8. PubMed ID: 18724548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
    Lee JH; Lee KH; Choi JS; Zang DY; Kim SB; Kim SW; Suh C; Lee JS; Kim WK; Lee YS; Kim SH
    J Korean Med Sci; 1996 Apr; 11(2):118-26. PubMed ID: 8835758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: review and update on the use of defibrotide.
    Ho VT; Linden E; Revta C; Richardson PG
    Semin Thromb Hemost; 2007 Jun; 33(4):373-88. PubMed ID: 17525895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.
    Ho VT; Revta C; Richardson PG
    Bone Marrow Transplant; 2008 Feb; 41(3):229-37. PubMed ID: 17994121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Veno-occlusive disease of the liver after hemopoietic cell transplantation.
    Carreras E
    Eur J Haematol; 2000 May; 64(5):281-91. PubMed ID: 10863974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy.
    Haussmann U; Fischer J; Eber S; Scherer F; Seger R; Gungor T
    Haematologica; 2006 Jun; 91(6):795-800. PubMed ID: 16769582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoiding hepatic veno-occlusive disease: what do we know and where are we going?
    Bearman SI
    Bone Marrow Transplant; 2001 Jun; 27(11):1113-20. PubMed ID: 11551020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
    Qureshi A; Marshall L; Lancaster D
    Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplant hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.
    Ho V; Momtaz P; Didas C; Wadleigh M; Richardson P
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E3. PubMed ID: 16029969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficiency of prevention and treatment of veno-occlusive disease of the liver after allogeneic stem cell transplantation].
    Dong M; Lin Q; Wu XY
    Ai Zheng; 2008 Jun; 27(6):646-9. PubMed ID: 18570742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation?
    Johnson DB; Savani BN
    Exp Hematol; 2012 Jul; 40(7):513-7. PubMed ID: 22542577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
    Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation.
    Ohashi K; Tanabe J; Watanabe R; Tanaka T; Sakamaki H; Maruta A; Okamoto S; Aotsuka N; Saito K; Nishimura M; Oh H; Matsuzaki M; Takahashi S; Yonekura S
    Am J Hematol; 2000 May; 64(1):32-8. PubMed ID: 10815785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.